Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-06-14-Speech-4-336-750"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-06-14"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20120614.22.4-336-750"2
lpv:hasSubsequent	lp_eu:2012-06-14-Speech-4-337-0002
lpv:speaker	lp:Sergio Paolo Francesco Silvestris2
lpv:spokenAs	substitute; BUDG (2012-01-19--2014-06-30)3 member; AGRI (2012-01-19--2014-06-30)3 substitute; Delegation for relations with Albania, Bosnia and Herzegovina, Serbia, Montenegro and Kosovo (2009-09-16--2014-06-30)3 member; Delegation to the Parliamentary Assembly of the Union for the Mediterranean (2009-09-16--2014-06-30)3 member_of_the_bureau; EPP (2012-02-03--2014-06-30)3 unknown; Il Popolo della Libertà (2009-07-14--2013-12-11)3 member; Delegation for relations with the Maghreb countries and the Arab Maghreb Union (2009-09-16--2014-06-30)3
lpv:translated text	"On the basis of available data, it is estimated that around 400 000 silicone breast implants made by PIP (Poly Implant Prothèse) have been sold worldwide and these implants have been widely used in the United Kingdom, France, Spain, Germany and Italy – all EU Member States. In light of what has been learnt, the need to inform patients that in some cases breast implants are not permanent and may need to be replaced or removed is highlighted. Therefore I support the call for pre-market assessment of certain categories of medical devices and the introduction of a passport for implant recipients specifying the special characteristics of the implant, its potential health risks and the post-operative follow-up care measures associated with the implant; the passport would have to be signed by the surgeon and the patient, and would be valid as a consent form for the operation."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph